1. Cardiac involvements in myasthenia gravis associated with anti‐Kv1.4 antibodies. (5th July 2013) Authors: Suzuki, S.; Baba, A.; Kaida, K.; Utsugisawa, K.; Kita, Y.; Tsugawa, J.; Ogawa, G.; Nagane, Y.; Kuwana, M.; Suzuki, N. Journal: European journal of neurology Issue: Volume 21:Number 2(2014:Feb.) Page Start: 223 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Clinical and mutational spectrum of Charcot–Marie–Tooth disease type 2Z caused by MORC2 variants in Japan. (3rd August 2017) Authors: Ando, M.; Okamoto, Y.; Yoshimura, A.; Yuan, J.‐H.; Hiramatsu, Y.; Higuchi, Y.; Hashiguchi, A.; Mitsui, J.; Ishiura, H.; Fukumura, S.; Matsushima, M.; Ochi, N.; Tsugawa, J.; Morishita, S.; Tsuji, S.; Takashima, H. Journal: European journal of neurology Issue: Volume 24:Number 10(2017:Oct.) Page Start: 1274 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗